Cleared Traditional

K222095 - BASHIR Endovascular Catheter Ref. No. 7201, BASHIR S-B Endovascular Catheter, Ref. No. 7101 (FDA 510(k) Clearance)

Apr 2023
Decision
276d
Days
Class 2
Risk

K222095 is an FDA 510(k) clearance for the BASHIR Endovascular Catheter Ref. No. 7201, BASHIR S-B Endovascular Catheter, Ref. No. 7101. This device is classified as a Mechanical Thrombolysis Catheter (Class II - Special Controls, product code QEY).

Submitted by Thrombolex, Inc. (New Britain, US). The FDA issued a Cleared decision on April 20, 2023, 276 days after receiving the submission on July 18, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.5150. To Mechanically Disrupt Thrombus And/or Debris In The Peripheral Vasculature..

Submission Details

510(k) Number K222095 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2022
Decision Date April 20, 2023
Days to Decision 276 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code QEY - Mechanical Thrombolysis Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.5150
Definition To Mechanically Disrupt Thrombus And/or Debris In The Peripheral Vasculature.